CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Phase IB Study of NEO-PV-01 + Adjuvant With Nivolumab in Patients With Melanoma, Non-Small Cell Lung Carcinoma or Transitional Cell Carcinoma of the Bladder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02897765
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:17.482252+00:00
Published At: 2021-02-25T00:00:00+00:00
Record Updated At: 2021-02-25
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urinary Bladder Cancer", "Bladder Tumors", "Transitional Cell Carcinoma of the Bladder", "Malignant Melanoma", "Melanoma", "Skin Cancer", "Carcinoma, Non-Small-Cell Lung", "Lung Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-02-25"
protocolSection.identificationModule.nctId: "NCT02897765"
protocolSection.identificationModule.officialTitle: "An Open-label, Phase IB Study of NEO-PV-01 + Adjuvant With Nivolumab in Patients With Melanoma, Non-Small Cell Lung Carcinoma or Transitional Cell Carcinoma of the Bladder"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.